Literature DB >> 8297393

The Dbl oncogene product as a GDP/GTP exchange protein for the Rho family: its properties in comparison with those of Smg GDS.

H Yaku1, T Sasaki, Y Takai.   

Abstract

The dbl oncogene product (Dbl) showed the GDP/GTP exchange protein (GEP) activity on all the rho family small GTP-binding protein (G protein) members including RhoA and Rac1 as well as mCdc42. Dbl was active on both the lipid-modified and -unmodified forms of these small G proteins, but was much more active on the former form than on the latter form. In the presence of Rho GDI, an inhibitory GEP for the rho family members, the GEP activity of Dbl was markedly reduced. These properties of Dbl were partly different from those of Smg GDS, another GEP which is active not only on the rho family members but also on Ki-Ras and Rap1 and is active only on their lipid-modified form.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8297393     DOI: 10.1006/bbrc.1994.1116

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Involvement of a small GTP-binding protein (G protein) regulator, small G protein GDP dissociation stimulator, in antiapoptotic cell survival signaling.

Authors:  A Takakura; J Miyoshi; H Ishizaki; M Tanaka; A Togawa; Y Nishizawa; H Yoshida; S i Nishikawa; Y Takai
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

2.  In vivo dynamics of Rac-membrane interactions.

Authors:  Konstadinos Moissoglu; Boris M Slepchenko; Nahum Meller; Alan F Horwitz; Martin A Schwartz
Journal:  Mol Biol Cell       Date:  2006-04-05       Impact factor: 4.138

3.  SmgGDS is a guanine nucleotide exchange factor that specifically activates RhoA and RhoC.

Authors:  Brant Hamel; Elizabeth Monaghan-Benson; Rafael J Rojas; Brenda R S Temple; Daniel J Marston; Keith Burridge; John Sondek
Journal:  J Biol Chem       Date:  2011-01-17       Impact factor: 5.157

4.  Asef2 functions as a Cdc42 exchange factor and is stimulated by the release of an autoinhibitory module from a concealed C-terminal activation element.

Authors:  Michael J Hamann; Casey M Lubking; Doris N Luchini; Daniel D Billadeau
Journal:  Mol Cell Biol       Date:  2006-12-04       Impact factor: 4.272

5.  Activation of Dbl restores migration in polyamine-depleted intestinal epithelial cells via Rho-GTPases.

Authors:  Ramesh M Ray; Mitulkumar N Bavaria; Sujoy Bhattacharya; Leonard R Johnson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-03       Impact factor: 4.052

6.  ROM7/BEM4 encodes a novel protein that interacts with the Rho1p small GTP-binding protein in Saccharomyces cerevisiae.

Authors:  H Hirano; K Tanaka; K Ozaki; H Imamura; H Kohno; T Hihara; T Kameyama; K Hotta; M Arisawa; T Watanabe; H Qadota; Y Ohya; Y Takai
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

7.  RhoGDIgamma: a GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas.

Authors:  C N Adra; D Manor; J L Ko; S Zhu; T Horiuchi; L Van Aelst; R A Cerione; B Lim
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

8.  Rom1p and Rom2p are GDP/GTP exchange proteins (GEPs) for the Rho1p small GTP binding protein in Saccharomyces cerevisiae.

Authors:  K Ozaki; K Tanaka; H Imamura; T Hihara; T Kameyama; H Nonaka; H Hirano; Y Matsuura; Y Takai
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

9.  The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer.

Authors:  Andrew D Hauser; Carmen Bergom; Nathan J Schuld; Xiuxu Chen; Ellen L Lorimer; Jian Huang; Alexander C Mackinnon; Carol L Williams
Journal:  Mol Cancer Res       Date:  2013-11-06       Impact factor: 5.852

10.  Arachidonic acid stimulates cell adhesion through a novel p38 MAPK-RhoA signaling pathway that involves heat shock protein 27.

Authors:  Melissa C Garcia; Denise M Ray; Brad Lackford; Mark Rubino; Kenneth Olden; John D Roberts
Journal:  J Biol Chem       Date:  2009-06-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.